150 related articles for article (PubMed ID: 455220)
1. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
2. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
3. Uterine cervical dysplasia & herpes simplex virus.
Luthra UK; Kotwani BG; Kochhar M; Khurana B; Seth P; Mohapatra LN; Mitra AB; Bhatnagar P; Prabhakar AK; Agarwal SS
Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
[No Abstract] [Full Text] [Related]
4. [Cellular immunity in carcinoma of the uterine cervix].
Pasqualini RS; Giraudo Conesa LC; Chevallier R
Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
[No Abstract] [Full Text] [Related]
5. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell activity in patients with cervical cancer.
Seth P
Indian J Med Res; 1983 Nov; 78():689-93. PubMed ID: 6671715
[No Abstract] [Full Text] [Related]
7. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Chen SS; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
[TBL] [Abstract][Full Text] [Related]
8. Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.
van de Linde AW; Streefkerk M; Schuurman HJ; te Velde ER; Kater L
Br J Cancer; 1983 Jan; 47(1):147-53. PubMed ID: 6821628
[TBL] [Abstract][Full Text] [Related]
9. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
11. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
Dini MM; Lenzi L; Faiferman I
Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
[TBL] [Abstract][Full Text] [Related]
12. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
Ishiguro T; Sugitachi I; Katoh K
Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
[No Abstract] [Full Text] [Related]
13. The immunohistological demonstration of carcinoembryonic antigen in intra-epithelial and invasive squamous carcinoma of the cervix.
McDicken IW; Rainey M
Histopathology; 1983 Jul; 7(4):475-85. PubMed ID: 6350149
[TBL] [Abstract][Full Text] [Related]
14. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.
Aurelian L; Royston I; Davis HJ
J Natl Cancer Inst; 1970 Sep; 45(3):455-64. PubMed ID: 4331639
[No Abstract] [Full Text] [Related]
15. Cell-mediated immunity in patients with ovarian carcinoma.
Chen SY; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
[No Abstract] [Full Text] [Related]
16. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
Janda Z; Kanka J; Vonka V; Svoboda B
Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
[No Abstract] [Full Text] [Related]
17. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity in patients with cervical cancer.
Cerni C; Tatra G; Berger R; Micksche M
Oncology; 1979; 36(4):164-70. PubMed ID: 224356
[TBL] [Abstract][Full Text] [Related]
19. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
Aurelian L; Kessler II; Rosenshein NB; Barbour G
Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
[TBL] [Abstract][Full Text] [Related]
20. [Genital herpes and cervical cancer].
Grebeniuk BN; Shuvaeva NI; Grigor'ev VV; Posevaia TA; Shubladze AK
Vestn Dermatol Venerol; 1981 Feb; (2):9-12. PubMed ID: 6261479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
